open access

Vol 83, No 5 (2015)
ORIGINAL PAPERS
Submitted: 2015-09-08
Get Citation

Thrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary disease

Mohammad Hossein Rahimi-Rad, Sheida Soltani, Masome Rabieepour, Shagayegh Rahimirad
DOI: 10.5603/PiAP.2015.0056
·
Pneumonol Alergol Pol 2015;83(5):348-351.

open access

Vol 83, No 5 (2015)
ORIGINAL PAPERS
Submitted: 2015-09-08

Abstract

Introduction: Thrombocytopenia (TP) is associated with poor outcome in patients who are critically ill with pneumonia, burns, and H1N1 influenza. To our knowledge, no similar study in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has been conducted to date. The aim of this study was to determine the impact of platelet count on the outcome of patients with AECOPD.

Material and methods: Patients admitted to our teaching hospital for AECOPD were divided into two cohorts, those with and without TP. The outcome of all patients was followed.

Results: Of the 200 patients with AECOPD, 55 (27.5%) had TP. Of these, 14 (25.5%) died in the hospital, whereas of the 145 non-TP patents, 11 (7.5%) died (p-value = 0.001). There was a significantly higher transfer rate to the ICU and mechanical ventilation in TP patients. The mean platelet count was significantly lower in patients who died than those who were discharged (161,672 vs. 203,005 cell/μL; p-value = 0.017). There was negative correlation between duration of hospitalization and platelet count.

Conclusion: TP was associated with poor outcome in AECOPD. TP could be considered as a marker for the assessment of inflammation and prognosis in AECOPD patients based on its cost-effective features.

Abstract

Introduction: Thrombocytopenia (TP) is associated with poor outcome in patients who are critically ill with pneumonia, burns, and H1N1 influenza. To our knowledge, no similar study in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has been conducted to date. The aim of this study was to determine the impact of platelet count on the outcome of patients with AECOPD.

Material and methods: Patients admitted to our teaching hospital for AECOPD were divided into two cohorts, those with and without TP. The outcome of all patients was followed.

Results: Of the 200 patients with AECOPD, 55 (27.5%) had TP. Of these, 14 (25.5%) died in the hospital, whereas of the 145 non-TP patents, 11 (7.5%) died (p-value = 0.001). There was a significantly higher transfer rate to the ICU and mechanical ventilation in TP patients. The mean platelet count was significantly lower in patients who died than those who were discharged (161,672 vs. 203,005 cell/μL; p-value = 0.017). There was negative correlation between duration of hospitalization and platelet count.

Conclusion: TP was associated with poor outcome in AECOPD. TP could be considered as a marker for the assessment of inflammation and prognosis in AECOPD patients based on its cost-effective features.

Get Citation

Keywords

platelet count, thrombocytopenia, outcome, acute exacerbation of COPD, mortality

About this article
Title

Thrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary disease

Journal

Advances in Respiratory Medicine

Issue

Vol 83, No 5 (2015)

Pages

348-351

DOI

10.5603/PiAP.2015.0056

Bibliographic record

Pneumonol Alergol Pol 2015;83(5):348-351.

Keywords

platelet count
thrombocytopenia
outcome
acute exacerbation of COPD
mortality

Authors

Mohammad Hossein Rahimi-Rad
Sheida Soltani
Masome Rabieepour
Shagayegh Rahimirad

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl